NEW YORK, Feb. 3, 2021 /PRNewswire/ -- TMRW Life Sciences(TMRW) announces that it has launched the world's first automated cryo specimen management solution for embryos andeggsused in in vitro fertilization (IVF). TMRW's proprietary platform has been installed in multiple premier fertility clinics in the U.S., launching the modern era of integrated, software-enabled management of the millions of eggs and embryos central to modern IVF.

The TMRW platform arrives at a critical moment: during the COVID pandemic, with record numbers of patients initiating egg freezing, and some U.S. fertility clinics reporting as much as 50% increases in cycle volume over the same period last year. Clinics accounting for more than 30% of all U.S. IVF cycles are scheduled to install the TMRW platform in 2021.

The CDC estimates that by 2025,22 million fertilitypatients globally will require egg and embryo storage.TMRW's platform offers a groundbreaking answer to a challenge the global IVF community is now facing: how to safely manage, track and store hundreds of millions of frozen eggs and embryos.

Until today, the IVF community worldwide has employed the same manualstorage methods developed over 40 years ago.This system is characterized by the handwritten labeling of specimens and a reliance on analog tracking and record keeping. In addition, there has been no cloud-based, electronic monitoring, or sensor technologydeployed to safeguard the containers holding the eggs and embryos which must be kept consistently at cryogenic temperatures.

"No one undertaking IVF should ever have to worry about the safety of their embryos and eggs," said Joshua Abram, Founder and Co-CEO of TMRW. "300 million babies are expected to be born via IVF globally by 2100. With TMRW we have brought the safe storage and management of life's most precious cells into the 21st Century."

Each TMRW platform safeguards the fertility specimens of as many as 4,000 patients. The system brings an unprecedented level of safety to every phase of the management of eggs and embryos, from accurate identification and chain of custody of every patient's samples via radio frequency identification (RFID) tracking, to continuous monitoring through TMRW's data-encrypted and HIPAA-compliant software. Taken together, TMRW's solutionprovides patients and clinicians alike transparency and peace of mind about the careof their eggs and embryos.

Vios Fertility Institute is the first fertility clinic to bring TMRW's platform online.

"As we see a substantial increase in patients seeking IVF and egg freezing -- up 41% percent and 31.5%, respectively, over last year -- I am thrilled that we are the first fertility clinic in the world to offer TMRW to its patients," said Dr. Angie Beltsos, CEO & Chief Medical Officer of Vios. "IVF patients and those wanting to preserve their fertility deserve the most sophisticated care available, and there is nothing more powerful than combining our top-notch embryology services with TMRW's game-changing technology. TMRW gives doctors, embryologists, and patients great reassurance."

Chicago couple Mayrav Dolgin and Renee Genova have received fertility treatments at Vios resulting in two healthy sons -- Jonah (age 2) and Elan (age 6 months). They are the first patients to have their remaining frozen embryos stored with the TMRW platform.

"The fertility journey can be difficult enough without having to worry about the safety of your embryos," explained Dolgin. "Mayrav and I were ecstatic to learn that ours would be the first to be stored in TMRW," added Genova. "Knowing that our remaining embryos will be cared for and looked after with the most advanced technology available gives us tremendous reassurance that our ability to continue building our family in the future is protected."

The TMRW platform key proprietary features include:

TMRW is expanding globally and will be in UK-based fertility clinics in the summer of 2021.

About TMRW Life Sciences:TMRW has created the world's first automated platform designed specifically for cryo-management of eggs and embryos used in IVF. TMRW's RFID-enabled, complete digital chain of custody SaaS technology radically improves on the error-prone manual and analog methods that have gone unchanged throughout the history of IVF, significantly reducing the chances of implantation mix-ups or loss of eggs and embryos. The TMRW team includes many of the world's most celebrated innovators in fertility, embryology, cryo-management, automation, software development and robotics to name a few of the disciplines involved. TMRW's co-founders, Joshua Abram, Alan Murray, and Dr. Jeffrey Port, are serial tech and life sciences entrepreneurs. Their immediate prior ventures sold for a combined sum of more than $1 billion. For more information, please visit TMRW.org.

About ViosFertility Institute:Established in 2015, Vios Fertility Institute is one of the fastest growing fertility clinics in the U.S., with 11 locations in the Chicago, Milwaukee and St. Louis regions. Woman owned, the Vios mission is to help patients find their way to fertility health with the highest chances of success. Vios offers innovative, scientific, and cutting-edge treatment options along with an unparalleled patient experience. http://www.ViosFertility.com

Media Contact:Emily GrosserDini von Mueffling Communications[emailprotected]757-645-5190

SOURCE TMRW Life Sciences

See the original post here:
TMRW Launches World's First Automated Platform to Safeguard Millions of Frozen Eggs and Embryos Used in IVF - PRNewswire